mk 0663 has been researched along with misoprostol in 2 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (misoprostol) | Trials (misoprostol) | Recent Studies (post-2010) (misoprostol) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 4,611 | 1,522 | 1,686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespi, S; Hunsche, E; Moore, A; Pellissier, J; Phillips, C | 1 |
| Carvalho, JC; do Amaral, BC; Moraes, BM; Morimoto, MS; Perazzo, FF; Vieira, LG | 1 |
2 other study(ies) available for mk 0663 and misoprostol
| Article | Year |
|---|---|
Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etoricoxib; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Models, Economic; Osteoarthritis; Proton Pump Inhibitors; Pyridines; Quality-Adjusted Life Years; Risk; Sulfones; Time Factors; United Kingdom | 2004 |
Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Carrageenan; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Edema; Etoricoxib; Male; Mice; Misoprostol; Pain; Pain Measurement; Pyridines; Rats; Rats, Wistar; Sulfones | 2007 |